| Year |
Citation |
Score |
| 2017 |
Kitamura A, Manso Y, Duncombe J, Searcy J, Koudelka J, Binnie M, Webster S, Lennen R, Jansen M, Marshall I, Ihara M, Kalaria RN, Horsburgh K. Long-term cilostazol treatment reduces gliovascular damage and memory impairment in a mouse model of chronic cerebral hypoperfusion. Scientific Reports. 7: 4299. PMID 28655874 DOI: 10.1038/S41598-017-04082-0 |
0.378 |
|
| 2015 |
Bachstetter AD, Van Eldik LJ, Schmitt FA, Neltner JH, Ighodaro ET, Webster SJ, Patel E, Abner EL, Kryscio RJ, Nelson PT. Disease-related microglia heterogeneity in the hippocampus of Alzheimer's disease, dementia with Lewy bodies, and hippocampal sclerosis of aging. Acta Neuropathologica Communications. 3: 32. PMID 26001591 DOI: 10.1186/S40478-015-0209-Z |
0.34 |
|
| 2015 |
Webster SJ, Van Eldik LJ, Watterson DM, Bachstetter AD. Closed head injury in an age-related Alzheimer mouse model leads to an altered neuroinflammatory response and persistent cognitive impairment. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 35: 6554-69. PMID 25904805 DOI: 10.1523/Jneurosci.0291-15.2015 |
0.345 |
|
| 2014 |
Webster SJ, Bachstetter AD, Nelson PT, Schmitt FA, Van Eldik LJ. Using mice to model Alzheimer's dementia: an overview of the clinical disease and the preclinical behavioral changes in 10 mouse models. Frontiers in Genetics. 5: 88. PMID 24795750 DOI: 10.3389/Fgene.2014.00088 |
0.492 |
|
| 2013 |
Webster SJ, Bachstetter AD, Van Eldik LJ. Comprehensive behavioral characterization of an APP/PS-1 double knock-in mouse model of Alzheimer's disease. Alzheimer's Research & Therapy. 5: 28. PMID 23705774 DOI: 10.1186/Alzrt182 |
0.415 |
|
| 2012 |
Webster SJ, Mruthinti S, Hill WD, Buccafusco JJ, Terry AV. An aqueous orally active vaccine targeted against a RAGE/AB complex as a novel therapeutic for Alzheimer's disease. Neuromolecular Medicine. 14: 119-30. PMID 22415896 DOI: 10.1007/S12017-012-8176-Z |
0.564 |
|
| 2011 |
Webster SJ, Wilson CA, Lee CH, Mohler EG, Terry AV, Buccafusco JJ. The acute effects of dimebolin, a potential Alzheimer's disease treatment, on working memory in rhesus monkeys. British Journal of Pharmacology. 164: 970-8. PMID 21486290 DOI: 10.1111/J.1476-5381.2011.01432.X |
0.623 |
|
| 2011 |
Terry AV, Callahan PM, Hall B, Webster SJ. Alzheimer's disease and age-related memory decline (preclinical). Pharmacology, Biochemistry, and Behavior. 99: 190-210. PMID 21315756 DOI: 10.1016/J.Pbb.2011.02.002 |
0.594 |
|
| 2010 |
Mitchell MB, Buccafusco JJ, Schade RF, Webster SJ, Mruthinti S, Harrell DU, Gulati NK, Miller LS. RAGE and Abeta immunoglobulins: relation to Alzheimer's disease-related cognitive function. Journal of the International Neuropsychological Society : Jins. 16: 672-8. PMID 20441687 DOI: 10.1017/S1355617710000469 |
0.575 |
|
| 2009 |
Buccafusco JJ, Webster SJ, Terry AV, Kille N, Blessing D. Protracted cognitive effects produced by clonidine in Macaca nemestrina performing a delayed matching task. Psychopharmacology. 202: 477-85. PMID 18784917 DOI: 10.1007/S00213-008-1318-1 |
0.596 |
|
| 2008 |
Buccafusco JJ, Terry AV, Webster SJ, Martin D, Hohnadel EJ, Bouchard KA, Warner SE. The scopolamine-reversal paradigm in rats and monkeys: the importance of computer-assisted operant-conditioning memory tasks for screening drug candidates. Psychopharmacology. 199: 481-94. PMID 17657478 DOI: 10.1007/S00213-007-0887-8 |
0.651 |
|
| 2008 |
Buccafusco JJ, Terry AV, Webster SJ. O4-04-01: Prolonged cognitive enhancement exhibited by monkeys after single doses of clonidine Alzheimer's & Dementia. 4: T190-T191. DOI: 10.1016/J.Jalz.2008.05.527 |
0.568 |
|
| 2007 |
Sood A, Warren Beach J, Webster SJ, Terry AV, Buccafusco JJ. The effects of JWB1-84-1 on memory-related task performance by amyloid Abeta transgenic mice and by young and aged monkeys. Neuropharmacology. 53: 588-600. PMID 17698153 DOI: 10.1016/J.Neuropharm.2007.06.028 |
0.619 |
|
| Show low-probability matches. |